The IPO is now live. Monitor for the pricing announcement, expected within 1-2 days, which will reveal the offering size and price. The stock will begin trading shortly after pricing. Given the early-stage nature, focus on the company's pipeline and cash runway disclosed in the final prospectus.
Price Chart
Executive Summary
BlossomHill Therapeutics' S-1 registration statement for its initial public offering was declared effective by the SEC on August 6, 2026. The company, a clinical-stage biopharmaceutical firm, can now proceed to price and list its common stock on the Nasdaq Global Select Market under the ticker BLSM. This is a critical milestone enabling the IPO to move forward, with pricing expected imminently.
Key Facts
- S-1 registration declared effective by SEC on August 6, 2026.
- IPO of common stock; company is a clinical-stage biopharmaceutical company.
- Listing sought on The Nasdaq Global Select Market under symbol BLSM.
- Underwriters include J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, and H.C. Wainwright & Co.
- Offering size and price range not yet disclosed (placeholder amounts in S-1).
Financial Impact
IPO proceeds to company are undisclosed; offering size and price range are placeholder amounts in the S-1.
Risk Factors
- IPO pricing and demand are unknown; offering size may be adjusted.
- Clinical-stage biotech with no approved products; high risk of pipeline failure.
- Post-IPO lockup expiration could create selling pressure.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002565 |
| Document: 9999999995-26-002565-index.html | 9999999995-26-002565 |
| Document: 9999999995-26-002565.txt | 9999999995-26-002565 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | Press Release | $21.34 $16.39 | ▲ +23.20% | ▲ +23.16% | $16.39 (+23.20%) |
Sep 18, 2026 5w ago | 8-K | $25.74 $13.94 | ▲ +45.84% | ▲ +46.05% | $16.39 (+36.32%) |
Sep 18, 2026 5w ago | Press Release | $25.74 $13.94 | ▼ −45.84% | ▼ −46.05% | $16.39 (−36.32%) |
Sep 15, 2026 5w ago | 8-K | $22.17 $15.48 | ▼ −30.18% | ▼ −33.15% | $16.39 (−26.07%) |
Aug 12, 2026 10w ago | Insider Cluster | $16.35 $20.86 | ▲ +27.58% | ▲ +29.33% | $16.39 (+0.24%) |
Aug 10, 2026 11w ago | Insider Cluster | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $16.39 (−0.79%) |
Aug 10, 2026 11w ago | 8-K | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $16.39 (−0.79%) |
Aug 7, 2026 11w ago | 424B4 | $15.99 $22.93 | ▲ +43.40% | ▲ +44.32% | $16.39 (+2.50%) |
Aug 7, 2026 11w ago | EFFECT | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $16.39 (+2.44%) |
Aug 6, 2026 11w ago | 3 | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $16.39 (+2.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers